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ABSTRACT: Recent studies suggest that exposure to endocrine-disrupting compounds (EDCs) may play a role in the
development of obesity. EDCs such as the ﬂame retardant 2,2′,4,4′-tetrabrominated diphenyl ether (BDE-47) have been shown
to enhance adipocyte diﬀerentiation in the murine 3T3-L1 model. The mechanisms by which EDCs direct preadipocytes to form
adipocytes are poorly understood. Here, we examined transcriptional and epigenetic mechanisms underlying the induction of in
vitro adipocyte diﬀerentiation by BDE-47. Quantitative high content microscopy revealed concentration-dependent enhanced
adipocyte diﬀerentiation following exposure to BDE-47 or the antidiabetic drug troglitazone (TROG). BDE-47 modestly
activated the key adipogenic transcription factor peroxisome proliferator-activated receptor gamma (PPARγ) in COS7 cells,
transiently transfected with a GAL4 reporter construct. Increased gene expression was observed for Pparγ2, leptin (Lep), and
glucose-6-phophatase catalytic subunit (G6pc) in diﬀerentiated 3T3-L1 cells after BDE-47 exposure compared to TROG.
Methylation-sensitive high resolution melting (MS-HRM) revealed signiﬁcant demethylation of three CpG sites in the Pparγ2
promoter after exposure to both BDE-47 and TROG in diﬀerentiated 3T3-L1 cells. This study shows the potential of BDE-47 to
induce adipocyte diﬀerentiation through various mechanisms that include Pparγ2 gene induction and promoter demethylation
accompanied by activation of PPARγ, and possible disruption of glucose homeostasis and IGF1 signaling.
■ INTRODUCTION
The generally accepted cause of obesity is an imbalance
between energy intake and expenditure, but this cannot account
for the total increase of this disease worldwide.1 Among other
risk factors, evidence is increasing that exposure to endocrine-
disrupting chemicals (EDCs), also known as obesogens, can
have adverse eﬀects on adipogenesis, lipid metabolism, and
body weight as found in epidemiological, in vivo, and in vitro
studies.2 In animal studies, (perinatal) exposure to several
EDCs has been related to an increase in adipose tissue and
body weight, for example diethylstilbestrol (DES)3 and
tributyltin (TBT).4 Bisphenol A (BPA) exposure has also
been shown to increase body weight in rodents,5 as well as to
induce adipocyte diﬀerentiation in vitro in the 3T3-L1 murine
preadipocyte diﬀerentiation model, at concentrations as low as
10 nM.6
We recently demonstrated a novel stimulatory adipogenic
eﬀect of BDE-47 in 3T3-L1 cells.7 BDE-47 is a ﬂame retardant
found throughout the world in diﬀerent matrixes, e.g., human
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blood, milk, dust, and various types of food.8 BDE-47 has been
shown to have endocrine-disrupting properties in vitro and in
vivo.9,10 Recent studies indicate that BDE-47 exposure also
aﬀects metabolic pathways in vivo, as an increase in body
weight has been observed in male mice postnatally exposed to
BDE-47, although no speciﬁc adipogenic end points were
measured.11 Additionally, prenatal exposure to BDE-47 in rats
aﬀected body weight in both male and female oﬀspring which
was accompanied by changes in several key processes in glucose
homeostasis and fat metabolism exclusively for males.5,6
Despite the recent data on increased body weight and enhanced
3T3-L1 adipogenesis by BDE-47, the molecular mechanisms
behind these changes remain unknown.
Recent insights into the diﬀerentiation of 3T3-L1 cells
provide a basis for understanding possible transcriptional
mechanisms by which EDCs such as BDE-47 direct
preadipocytes to form adipocytes. Adipocyte diﬀerentiation
involves major transcriptional regulatory steps in which
peroxisome proliferator-activated receptor gamma 2
(PPARγ2), an isoform of PPARγ predominantly expressed in
adipose tissue, is known to be the master regulator.14,15
Diﬀerentiation of 3T3-L1 cells is driven by two waves of
transcription factors.16 The ﬁrst wave is directly activated by an
adipogenic cocktail consisting of 3-isobutyl-1-methylxanthine
(IBMX), dexamethasone, and insulin (MDI cocktail) and
includes induction of CAAT/enhancer-binding proteins β (C/
EBPβ) and C/EBPδ. Subsequently, a second wave of late-acting
adipogenic transcription factors is induced, including C/EBPα
and PPARγ, which in turn activate the adipogenic gene
program. PPARγ binds as an obligate heterodimer with retinoid
X receptor (RXR) to thousands of sites in the genome15 and
appears to be directly involved in the activation of most
adipocyte speciﬁc genes, such as lipoprotein lipase (LPL), fatty
acid binding protein 4 (FABP4), glucose transporter type 4
(SLC2A4), and adiponectin (ADIPOQ) as well as the PPARγ-
independent adipokine leptin (LEP) (Figure 1).14 Several
studies have shown that some compounds that stimulate
adipogenesis, such as tributyltin (TBT)4 and butylparaben,17
act via the known adipogenic pathway of PPARγ and/or RXRα
activation while others, such as 2,2′4,4′,5,5′-hexachlorinated
biphenyl (CB-153)17 and bisphenol A diglycidyl ether
(BADGE),6 increase diﬀerentiation of 3T3-L1 cells through
mechanisms independent of PPARγ activation.
Furthermore, EDCs may inﬂuence epigenetic processes
during adipogenesis. The epigenome of the adipocyte is
extensively modiﬁed as part of the transcriptional reprogram-
ming during adipogenesis, which involves histone-modifying
complexes as well as the more stable DNA methylation
mark.18−21 For instance, compared to undiﬀerentiated 3T3-L1
cells, demethylation was observed in diﬀerentiated 3T3-L1 cells
within a CpG island (CGI) at the leptin (Lep) promoter.22
Hypomethylation has also been found in a regulatory region of
the promoter of Pparγ2 after diﬀerentiation of 3T3-L1 cells,
which was linked to increased gene expression.23 Increasing
evidence suggests involvement of EDCs in DNA methylation
mechanisms,24 and therefore EDCs could possibly aﬀect DNA
methylation in promoter regions of genes of key adipogenic
transcription factors. A direct link between exposure to
adipogenic compounds and DNA methylation at promoters
of speciﬁc adipogenic loci has not been reported to our
knowledge, but animal studies have shown that exposure to
EDCs such as DES and BPA can aﬀect both body weight and
CpG methylation at several loci.25,26 Furthermore, we have
found that diﬀerentiation of 3T3-L1 cells by EDCs such as
TBT is accompanied by global demethylation.7 In the same
study, a modest decrease in global methylation was also found
after exposure of 3T3-L1 cells to BDE-47, though the speciﬁc
loci aﬀected were not identiﬁed.
Here, we examine the transcriptional and epigenetic
mechanisms underlying the stimulation of 3T3-L1 adipocyte
diﬀerentiation by BDE-47. Insulin-sensitizing drugs, thiazolidi-
nediones (TZDs), were used as reference compounds in this
study, as they are known to be potent ligands for PPARγ.27 Our
results indicate that the eﬀects of BDE-47 on 3T3-L1
adipogenesis are partly mediated through activation, gene
induction, and promoter demethylation of PPARγ2.
■ MATERIALS AND METHODS
Chemicals. The thiazolidinedione troglitazone (TROG;
>98%) was obtained from Sigma Aldrich (Germany). LG268
was a gift of Dr. R. Heyman (Ligand Pharmaceuticals), and
rosiglitazone (ROSI) was obtained from BioMol (Farmingdale,
NY). BDE-47 was synthesized at Stockholm University and
charcoal puriﬁed to remove impurities such as brominated
Figure 1. Genes involved in adipogenesis and analyzed in this study.
During the course of diﬀerentiation, two waves of transcription factors
direct preadipocytes to change into adipocytes. In 3T3-L1 cells, the
ﬁrst wave is induced by a cocktail of IBMX, dexamethasone, and
insulin (MDI), causing enhanced transient transcription of CAAT/
enhancer binding proteins, Cebpβ and Cebpδ, followed by expression
of sterol-responsive element binding protein 1a (Srebf1a). These
transcription factors induce a second wave of transcription factors
(Pparγ2 and Cebpα). PPARγ2 will form a heterodimer with retinoic x
receptor (RXR), causing expression of PPARγ2 targets such as fatty
acid binding protein 4 (Fabp4), lipoprotein lipase (Lpl), glucose
transporter type 4 (Slc2a4), and adiponectin (Adipoq). Mature
adipocytes will diﬀerentially express genes involved in glucose
homeostasis compared to preadipocytes (e.g., increases in glucose 6
phosphatase catalytic subunit (G6pc), insulin growth factor 1 (Igf1),
leptin (Lep), and insulin receptor (Insr), and a decrease in insulin
growth factor receptor (Igf r)).14,40−42
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dibenzofurans and dioxins and was kindly provided by
Professor Åke Bergman (Stockholm University, Sweden).
Compounds were dissolved in DMSO (99.9%) obtained from
Acros Organics (Belgium).
3T3-L1 Cell Culture. 3T3-L1 cells (ATCC, Manassas, VA)
were maintained in DMEM (high glucose, 15 mM HEPES, and
glutamax) (Gibco, The Netherlands), supplemented with 1×
nonessential amino acids (Gibco, The Netherlands), 10% FCS
(Sigma Aldrich, Germany), and penicillin/streptomycin
(Gibco, The Netherlands). Cells were subcultured twice a
week at 70−80% conﬂuence. All experiments were performed
at passage 6.
Diﬀerentiation Experiments. Diﬀerentiation experiments
were performed as described previously.7 Cells were seeded in
culture medium at a density of 15 000 cells/cm2 in 6 (RNA/
DNA analysis) or 48 (Cellomics analysis) well plates in a
volume of 2 or 0.2 mL, respectively. For RNA/DNA analysis, 2
wells per treatment were included. For Cellomics analysis, 3
wells per treatment were used. Two days after reaching
conﬂuency (t = 0), cells were exposed to diﬀerent
concentrations of BDE-47, TROG, or vehicle (DMSO, 0.1%)
in 2 mL (6 well) or 0.25 mL (48 well) in diﬀerentiation
medium (MDI medium), consisting of 1.67 μM insulin (Roche,
The Netherlands), 1 μM dexamethasone (Sigma Aldrich,
Germany), and 5 mM 3-isobutyl-1-methylxanthine (IBMX)
(Sigma Aldrich, Germany) in culture medium. Using the same
conditions, the exposures were refreshed after 24 h. Two days
after starting induction of diﬀerentiation, MDI medium was
replaced with culture medium containing only the test
compounds or vehicle. This step was repeated at day 4 and
6. Experiments were ﬁnalized at day 8. During the experiments,
undiﬀerentiated cells were used as an untreated control
(undiﬀerentiated control) and MDI-induced cells (diﬀer-
entiated control, 0.1% DMSO) were used as a vehicle control
of basal diﬀerentiation. Two independent experiments were
performed for both RNA/DNA and Cellomics analysis.
Analysis of Adipocyte Diﬀerentiation. 3T3-L1 cells
were analyzed after 8 days using high-content microscopy by
Cellomics Arrayscan technology (Thermo Scientiﬁc, The
Netherlands). Cells were ﬁxed in 4% paraformaldehyde
(Sigma, Germany) and stained with 1 μg/mL Hoechst 33258
(Invitrogen, Grand Island, NY) and 10 μg/mL Nile Red (Sigma
Aldrich, Germany) in 0.25 mL milli-Q water. Stained cells were
analyzed by Cellomics Arrayscan high-content microscopy
(Thermo Scientiﬁc, The Netherlands) at 10× magniﬁcation.
From each well, 80 image ﬁelds were scanned and analyzed
using the compartmental analysis bio application (v3.0),
designed to quantify compartmentalized changes in ﬂuores-
cence.28 End points measured were total number of cells and
adipocytes, adipocyte cell size, and the number of fat droplets
per cell.
Gene Expression Analysis. Total RNA was isolated and
puriﬁed from 3T3-L1 cells with the Nucleospin RNAII
extraction kit (Macherey-Nagel, Germany). Equal amounts of
RNA were converted into cDNA with the high capacity cDNA
RT kit (Applied Biosystems, Grand Island, NY), according to
manufacturer’s recommendations. Subsequently, cDNA was
diluted 20× in Milli-Q water prior to QPCR. QPCR
experiments were performed in duplicate per sample on the
ECO QPCR system (Illumina Inc., San Diego, CA) in 5 μL
reactions, containing ABsolute QPCR SYBR Green Mix
(Thermo Scientiﬁc, The Netherlands), 250 nM primer mix,
and 2 μL of 20× diluted template using the following program:
95 °C for 15 min; 40 cycles of 95 °C for 15 s; 60 °C for 45 s.
Primers were tested for eﬃciency, dimers, and nonspeciﬁc
products (Supporting Information Table 1). After assessment
of candidate reference genes (Hprt, Nono, and Bactin), Bactin
showed the most stable Cq values relative to the amount of
input RNA for cDNA synthesis and was therefore regarded as
unaﬀected during diﬀerentiation and between the diﬀerent
exposures (data not shown). Expression was calculated relative
to the diﬀerentiated control of day 1, as described earlier.29
PPARγ and RXRα Reporter Gene Assays. GAL4-hPPARγ
and GAL4-hRXRα transfection assays in COS7 cells were
performed as previously described.6 ROSI and LG268 were
used as a positive control for PPARγ and RXRα, respectively.
BDE-47 was tested up to 33 μM in 0.1% DMSO. Each
experiment contained triplicate replicates, and at least two
independent experiments were performed.
Methylation-Sensitive High Resolution Melting (MS-
HRM) Analysis. MS-HRM analysis was performed based on
net temperature shift (NTS) calculations as described by
Newman and colleagues.30 Extended experimental procedures
are found in Supporting Information. In short, DNA was
bisulﬁte converted using the Epitect Bisulﬁte Kit (Qiagen,
Germany) as described by the manufacturer. Diﬀerent ratios of
unmethylated toward fully methylated control DNA of a
speciﬁc promoter region were produced to generate a
calibration curve. After bisulﬁte conversion and PCR of control
DNA and unknown samples, HRM analysis was performed on
the ECO QPCR system (Illumina Inc.). Percentage methyl-
ation was calculated by interpolating unknowns in the
calibration curve. Analyses were performed in duplicate on
each of two independent experiments.
Direct Sequencing. To conﬁrm HRM results, bisulﬁte
sequencing reactions were performed with the Big Dye
Terminator Kit 1.1 (Applied Biosciences), using the forward
primer of leptin CGI1 (Supporting Information Table 2b) in
samples from one experiment. Reaction conditions were 1 μL
of 10 μM primer, 4 μL of 2.5× reaction buﬀer, 1 μL of premix,
and 20× diluted PCR sample (from HRM reactions) up to a
volume of 10 μL. Cycling conditions were 96 °C for 10 s, 59 °C
for 10 s, and 60 °C for 75 s for 25 cycles. Products were
puriﬁed by adding 40 μL of water and 5 μL of 3 M sodium
acetate (Sigma-Aldrich, Germany) to the samples to precipitate
DNA. After centrifugation (13 000 rpm, 25 min), samples were
rinsed twice with ethanol (P.A., Sigma-Aldrich, Germany) and
centrifuged again (13 000 rpm, 1 min). Finally, samples were
dissolved in 30 μL of water and analyzed on the 3730 DNA
analyzer (Applied Biosystems). Sequence Analysis software
(v5.1.1, Applied Biosystems) was used to measure the peak
intensity of thymidine (T) and cytosine (C) at CpG sites. The
C/T ratio was calculated as a measure for methylation status of
CpG sites.
Statistical Analysis. Statistical calculations were performed
with GraphPad Prism software (v5.04, Graphpad Software Inc.,
La Jolla, CA). Data were analyzed by two-way ANOVA with
treatment and experiment number as independent variables. In
case no main eﬀect or interaction eﬀect were found for replicate
experiments, congregated data of two experiments were
analyzed by one-way ANOVA. Diﬀerences between treatments
were analyzed by Bonferroni’s multiple comparison posthoc
tests (P < 0.05).
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■ RESULTS
Adipocyte Diﬀerentiation. We developed a high
throughput analysis system for measuring adipocyte diﬀer-
entiation in 48-well plates, using a double Nile Red/Hoechst
stain to quantify the increase in adipocyte cell number by
TROG and BDE-47 exposure compared to the undiﬀerentiated
and diﬀerentiated controls (Figure 2, parts c,d vs a,b). In two
independent experiments, a reproducible concentration−
response-related increase was found by BDE-47 and TROG
both in cell proliferation which occurs during the ﬁrst wave of
transcription factor induction (data not shown) and diﬀer-
entiation to adipocytes after 8 days (Figure 2e). We optimized
the 3T3-L1 diﬀerentiation conditions to obtain a relatively low
level of diﬀerentiation in the diﬀerentiated controls (17%),
which allowed for enhanced discrimination of the eﬀects of the
test chemicals on adipocyte diﬀerentiation (up to 38% and 76%
for BDE-47 and TROG, respectively) (Figure 2e). Based on
congregated data of two experiments, a signiﬁcant increase in
adipocytes was found compared to the diﬀerentiated control at
the lowest level tested, namely 3 nM (17.2% for diﬀerentiated
control vs 22.4% and 22.1% for BDE-47 and TROG,
respectively) (Figure 2e). No signiﬁcant eﬀect was found on
adipocyte cell size by either TROG or BDE-47 (data not
shown).
Transactivation of PPARγ and RXRα. The observed
increase in adipocyte diﬀerentiation by BDE-47 in 3T3-L1 cells
led us to examine the possibility that BDE-47 may be a ligand
for PPARγ and/or RXRα. In transient transfection assays in
COS7 cells with GAL4-hPPARγ, concentration-dependent
PPARγ activation was observed for BDE-47 up to 33 μM,
though the maximum induction (up to 3×) was much lower
compared to the 150× induction by the TZD reference
compound rosiglitazone (ROSI) (Figure 3a). Exposure to
higher concentrations up to 100 μM BDE-47 conﬁrmed these
results by showing a stronger activation of PPARγ (7×, data not
shown). In GAL4-RXRα-transfected COS7 cells no activation
of RXRα was observed after BDE-47 exposures, though the
reference RXRα ligand LG268 showed distinct concentration-
related eﬀects (Figure 3b).
Expression of Adipogenic Genes during Diﬀerentia-
tion. Because we observed only weak activation of PPARγ by
BDE-47, the transcriptional mechanism of action underlying
BDE-47-enhanced adipocyte diﬀerentiation was further studied.
Expression of several key genes involved in 3T3-L1 adipo-
genesis was measured at various time points during induced
diﬀerentiation by BDE-47 or TROG exposures (Figure 4).
Expression was calculated relative to the diﬀerentiated control
of day 1. To obtain maximum diﬀerences in gene expression,
BDE-47 and TROG were tested at concentrations exhibiting
the highest compound speciﬁc adipocyte diﬀerentiation with no
visual cytotoxic eﬀects, i.e., 25 μM and 1 μM, respectively.
Furthermore, these concentrations showed no cytotoxic eﬀects
in lactate dehydrogenase leakage (LDH) and 3-(4,5-dime-
thylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as-
Figure 2. Quantiﬁcation of 3T3-L1 diﬀerentiation with Cellomics Arrayscan technology. Nile red (green) and Hoechst (blue) staining of (a)
undiﬀerentiated cells, and diﬀerentiated cells exposed to (b) diﬀerentiated control (DMSO), (c) BDE-47 (25 μM), and (d) TROG (1 μM). (e)
Concentration-dependent eﬀect of BDE-47 and TROG on adipocyte diﬀerentiation, with a cutout at 3 nM showing signiﬁcant enhancement of
diﬀerentiation. (Graph is presented as mean ± SD from one out of two reproducible experiments; cutout is presented as mean ± SD of congregate
data of two experiments).
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says following exposure to BDE-47 for 72 h in undiﬀerentiated
3T3-L1 cells.7 When ﬁrst considering the diﬀerentiated control
(Figure 4), mRNA levels of Cebpβ and Cebpδ both increased
after day 1, followed by an increased expression of Srebf1a.
mRNA levels of Pparγ2 and Cebpα were elevated after the
initiation phase and were highly expressed during the whole
process of diﬀerentiation. The expression of PPARγ targets Lpl,
Slc2a4, Fabp4, and Adipoq was enhanced at day 3 and 8. During
the course of diﬀerentiation, increases in mRNA were observed
for G6pc, Lep, Igf1, and Insr, whereas a decrease was observed in
Igf1r.
Exposure of 3T3-L1 cells to BDE-47 or TROG during
diﬀerentiation only modestly aﬀected mRNA expression of the
transcription factors during the ﬁrst 2 days of diﬀerentiation
(Figure 4). A slight increase was observed for both Cebpβ and
Rxrα expression in response to both BDE-47 and TROG
compared to diﬀerentiated control at day 2. Expression of
Cebpβ was signiﬁcantly higher for BDE-47 than the diﬀer-
entiated control at this time point, while the expression of Rxrα
was signiﬁcantly higher for TROG. More pronounced diﬀer-
ences in gene expression between the two chemicals were
found at later stages in diﬀerentiation. Although TROG is a
more potent inducer of adipocyte diﬀerentiation than BDE-47,
only BDE-47 induced an increase in Pparγ2 mRNA expression
after 8 days. However, this diﬀerence in Pparγ2 expression was
not reﬂected in the PPARγ targets (Cebpα, Lpl, Slc2a4, and
Fabp4). Of those targets, TROG exhibited signiﬁcant increases
in expression at an earlier stage (at 2 and 3 days) and at a level
higher than that of BDE-47. Adipoq mRNA levels did not diﬀer
between exposures. Expression analysis of both G6pc and Lep
showed signiﬁcant enhancement exclusively by BDE-47
compared to the diﬀerentiated control (Figure 4).
DNA Methylation Analysis of the Pparγ2 and Lep
Promoter. To determine if the increased Pparγ2 expression at
8 days by BDE-47 exposure was linked to the methylation
status of the Pparγ2 promoter region, we employed
methylation-sensitive high resolution melting (MS-HRM).30
A region in the Pparγ2 promoter with three CpGs sites
between −337 and −192 base pairs from the transcription start
site (TSS) was selected based on a previous study (Figure
5a).23 This region, located within a DNase I hypersensitive
site,18 represents an open chromatin structure, where proteins
such as transcription factors are able to bind and potentially
regulate Pparγ2 expression. A calibration curve consisting of
control DNA mixtures with diﬀerent ratios of unmethylated vs
fully methylated CpGs was used to quantify the methylation
status of the region, based on net temperature shift (NTS)
calculations (Figure 5b). MS-HRM analysis revealed signiﬁcant
demethylation of the three CpGs present in this region after
diﬀerentiation with BDE-47 and TROG compared to
undiﬀerentiated cells (Figure 5c).
Because Lep mRNA expression was elevated by BDE-47
exposures compared to TROG and diﬀerentiated control, MS-
HRM analysis was also performed on the Lep promoter. The
promoter region of Lep contains three CpG islands (CGIs), as
deﬁned by the NCBI genome viewer (http://www.ncbi.nlm.
nih.gov/). Two of them (CGI1 and 2) were analyzed by MS-
HRM (Figure 6a). A high methylated state (approximately
70%) and no signiﬁcant diﬀerences between the exposures were
observed in the analyzed region of CGI1 (Figure 6c). These
results were validated by direct sequencing of the PCR products
obtained from the MS-HRM analysis, yielding a similar trend
for the methylated controls (0%, 50%, and 100% methylated) at
the eight analyzed CpG sites and conﬁrming that no diﬀerences
in methylation were observed between the diﬀerent exposures
(Figure 6d). The second CGI, located at a more distal region
upstream from the Lep promoter, also showed no diﬀerences
between the exposures (Figure 6f).
■ DISCUSSION
Enhanced Adipocyte Diﬀerentiation. Increasing evi-
dence suggests that exposure to EDCs may play a role in the
worldwide epidemic of obesity through various mechanisms
including eﬀects on adipocyte diﬀerentiation.2 This study
reveals that BDE-47, an endocrine-disrupting brominated ﬂame
retardant found ubiquitously in the environment, induces
adipocyte diﬀerentiation in 3T3-L1 cells at concentrations as
low as 3 nM. We developed a novel quantiﬁcation technique
using Cellomics Arrayscan technology, which represents a
signiﬁcant step forward from widely used techniques such as
Oil Red O, or Nile Red lipid staining combined with
spectrophotometric analysis or ﬂuorescence-activated cell
sorting (FACS). The Cellomics Arrayscan allowed fast and
accurate measurements of cell numbers, cell size, and cell type
(adipocytes) that parallels the accuracy of FACS and the high
throughput capacity of staining techniques, which allows us to
screen many compounds and environmental extracts for
adipogenic properties.
BDE-47 levels in North America are among the highest
reported throughout the world, generally 1 magnitude higher
than elsewhere and with no indication of decline.31 Levels
Figure 3. Transactivation of PPARγ and RXRα. (a) Rosiglitazone
(ROSI) shows over 150× higher induction in luciferase expression
relative to the vehicle control (DMSO). BDE-47 shows weak but
signiﬁcant activation of GAL4-PPARγ up to 2.5×. (b) Although the
known RXRα activator LG268 induces luciferase expression over 200
times, no activation is observed with BDE-47. Data are reported as
relative luciferase expression over vehicle (0.1% DMSO) controls
(mean ± SD) for triplicate samples (three biological replicates), and
similar results were obtained in additional experiments.
Environmental Science & Technology Article
dx.doi.org/10.1021/es405524b | Environ. Sci. Technol. XXXX, XXX, XXX−XXXE
reported in blood from US citizens range from 0.63 to 46 ng/g
(1.1 to 81.5 pmol/g or 0.008 to 0.6 nM) lipid weight, and these
levels indicate a minimal margin of exposure of only 5 when
compared to the 3 nM concentration used in the 3T3-L1
medium, based on an average lipid content in blood of 0.7%.8
Furthermore, the highest reported level of BDE-47 found in
serum from children working at waste disposal sites in Managua
(Nicaragua) was 384 ng/g (680 pmol/g) lipid weight (0.4%
lipid), corresponding to 2.8 nM in serum.32 Because these
levels are close to the concentrations used in this study, the
results cannot be neglected.
PPARγ Activation. Although many EDCs are able to
induce adipocyte diﬀerentiation in 3T3-L1 cells, the underlying
mechanisms have been elucidated for only a few. Here, we
show that BDE-47 weakly activates PPARγ, but not RXRα, in
transient transfection assays. The activation of PPARγ is likely
Figure 4. Gene expression analysis of selected targets involved in 3T3-L1 adipocyte diﬀerentiation in undiﬀerentiated (Undiﬀ control) or
diﬀerentiated cells following exposure to vehicle (0.1% DMSO, Diﬀ control), BDE-47 (25 μM), and TROG (1 μM). Initiation of diﬀerentiation
begins with a transient increase in expression of Srebf1a, Cebpβ, Cebpδ, and Rxrα, followed by an increase of Pparγ2 and Cebpα. Consequently,
adipocyte speciﬁc markers Lpl, Slc2a4, Fabp4, and Adipoq are increased. Genes involved in glucose homeostasis are altered in mature adipocytes, with
increases observed for G6pc, Lep, Igf1, and Insr, and a decrease in expression of Igf1r. (Figures represent one out of two reproducible experiments,
calculated relative to the diﬀerentiated control of day 1 (mean ± SD *BDE-47 signiﬁcantly diﬀerent compared to diﬀerentiated control, #TROG
signiﬁcantly diﬀerent compared to diﬀerentiated control. Signiﬁcance was calculated averaging two experiments (P < 0.05)).
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to be causally related to the signiﬁcantly increased expression of
many PPARγ target genes after exposure to 25 μM BDE-47
during diﬀerentiation. In previous studies, alkylated metals such
as tributyltin (TBT) have been shown to activate the PPARγ/
RXRα heterodimeric complex in murine and human adipose-
derived stromal stem cells4,33 and in 3T3-L1 cells.4 However,
other compounds such as BADGE and BPA,6 and PCB-153,17
have been shown to induce adipogenesis in 3T3-L1 cells by a
PPARγ/RXRα independent mechanism. These results indicate
that EDCs may exert adipogenic eﬀects via pathways other than
activation of key adipogenic transcription factors.
Diﬀerential Expression and Promoter Demethylation
of PPARγ. Because only weak activation of PPARγ by BDE-47
was observed during transient transfection experiments,
diﬀerential expression of several adipogenic target genes was
examined to investigate other transcriptional routes by which
BDE-47 could exhibit its adipogenic action. Generally, genes
involved in the initiation of adipocyte diﬀerentiation and
maturation exhibited the same trend for both BDE-47 and the
prototypical PPARγ ligand TROG compared to the diﬀer-
entiated control. However, the increased expression of Pparγ2
at 8 days of diﬀerentiation, exclusively after BDE-47 exposure,
was an unexpected ﬁnding. Though further analysis is needed,
the diﬀerence of Pparγ2 expression between BDE-47 and
TROG may be explained by the negative feedback of TROG on
Pparγ2 expression which has been reported in mature 3T3-L1
adipocytes.34 A similar repression may not occur in response to
BDE-47.
We investigated if the increased gene expression of Pparγ2
found after BDE-47 exposure was related to a decreased
methylation status of the Pparγ2 promoter. It has been
established that the chromatin structure of the Pparγ2
promoter is more open in diﬀerentiated than undiﬀerentiated
adipocytes and that several CpG sites are demethylated in the
promoter region of Pparγ2, which is linked to increased gene
expression.23 We quantiﬁed the methylation status of three
CpG sites on the Pparγ2 promoter and conﬁrmed that the
promoter is hypomethylated after diﬀerentiation which is
concurrent with the increased gene expression of Pparγ2.
Importantly, we show for the ﬁrst time that both BDE-47 and
TROG exposure resulted in signiﬁcant lower methylation levels
of the Pparγ2 promoter after diﬀerentiation. As the methylation
status of the Pparγ2 promoter was similar between BDE-47 and
TROG, despite the diﬀerences in gene expression, we
hypothesize that additional loci amenable to methylation or
other epigenetic processes involved in Pparγ2 expression could
be aﬀected by BDE-47, such as histone modiﬁcations.21,23
Disturbed Glucose Homeostasis. Higher levels of G6pc
mRNA were found in diﬀerentiated 3T3-L1 cells after BDE-47
exposures compared to TROG. G6pc encodes for the catalytic
subunit of glucose-6-phosphatase and is responsible for
maintaining intercellular glucose levels.35 Additionally, we
found that Igf1 mRNA levels increased up to 400 fold during
diﬀerentiation and were highest in BDE-47 exposed cells. It has
been shown that either insulin or IGF1 is essential to achieve
proper diﬀerentiation in 3T3-L1 cells in a dose-dependent
matter.36 Increased levels of IGF1 and increased recovery rates
of blood glucose in plasma have been found in male rats
perinatally exposed to BDE-47, accompanied by increased body
weight.12 The increased expression of G6pc found in livers of
these animals was suggested to be linked to the increased
glucose uptake.13 The elevated G6pc mRNA levels found with
BDE-47 exposure in this study, together with the increased Igf1
mRNA levels during diﬀerentiation, suggests a similar
mechanism of glucose homeostasis disruption in 3T3-L1
cells. The elevated expression of G6pc may also play a role in
the increased Lep expression observed after BDE-47 exposure.
Higher levels of G6pc cause higher levels of cytoplasmic
glucose,35 which subsequently could lead to increased LEP
levels. Accordingly, enhanced Lep expression and leptin release
in 3T3-L1 adipocytes has been observed after glucose
exposure.37 Further research is needed to conﬁrm a possible
Figure 5. Methylation analysis of the Pparγ2 promoter. (a) A schematic overview of the analyzed region showing three CpG sites at positions −240,
−269, and −298 from the transcription start site (TSS). (b) A typical calibration curve of percentage methylation (%CpG) plotted against the mean
net temperature shift (NTS) was used to interpolate samples (c) Methylation of the Pparγ2 promoter in DNA samples from undiﬀerentiated 3T3-L1
and diﬀerentiated cells exposed to vehicle control (0.1% DMSO), BDE-47 (25 μM), and TROG (1 μM). (Data for c are shown as the mean of two
independent experiments ± SD *signiﬁcantly diﬀerent from undiﬀerentiated cells, P < 0.05).
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link between BDE-47-mediated elevation of intracellular
glucose levels, G6pc expression, and leptin levels.
Changes in CGI methylation on the promoter of Lep,
induced either directly by BDE-47 or indirectly via enhanced
glucose levels, could have been a possible mechanism leading to
increased Lep gene expression, because hypomethylation of
CGIs at promoter regions of genes is associated with gene
expression, whereas hypermethylation is associated with long-
term silencing of genes.38 Demethylation of CGI1 of the Lep
promoter after 3T3-L1 diﬀerentiation has been previously
observed.22 However, in this study, Lep promoter methylation
was unchanged and highly methylated in all treatments and in
both undiﬀerentiated and diﬀerentiated 3T3-L1 cells, despite
the dramatic increase in gene expression of Lep after
diﬀerentiation. In concordance with our results, a recent animal
study also failed to show a relationship between Lep expression
and DNA methylation in adipose tissue.39 We infer that other
mechanisms mediated by BDE-47, such as upstream tran-
scription factor regulation or other epigenetic mechanisms (e.g
Figure 6. MS-HRM analysis of two CpG islands (CGIs) of the Lep promoter after exposure to BDE-47 (25 μm) and TROG (1 μM). (a) A region
between −104 and −290 base pairs from the TSS was analyzed in CGI1, which included 13 CpG sites. Another, more distal, CGI (CGI2) was
analyzed in a region ranging from −2612 to −2757 base pairs (6 CpG sites) from the TSS. (b,c) Calibration curve and the methylation status of
CGI1. (d) Direct sequencing results of 8 CpG sites in the ﬁrst CGI of the Lep promoter. (e, f) Calibration curve and methylation status of CGI2.
Data for c and e are shown as the mean of two independent experiments ± SD. Part d was performed on duplicate samples of one experiment.
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histone modiﬁcations), could be responsible for increased Lep
expression.
Our study shows adipogenic eﬀects of the ubiquitous
environmental contaminant BDE-47 at low nanomolar
concentrations and identiﬁes putative mechanisms underlying
the enhanced 3T3-L1 cell diﬀerentiation by BDE-47. We
propose that BDE-47 induces adipocyte diﬀerentiation in vitro
by increasing expression of Pparγ2 while weakly activating
PPARγ. BDE-47 also leads to decreased methylation of the
Pparγ2 promoter, which may play a role in the increased
Pparγ2 expression. A possible second mechanism suggests a
role for BDE-47 in disruption of glucose homeostasis and IGF1
signaling by increasing levels of IGF1 and G6PC, which may
ultimately result in enhanced Lep expression. Given the urgent
need to understand how exposure to chemicals may inﬂuence
obesity, the results found in this study provide new insights into
the complex transcriptional mechanisms that are associated
with enhanced adipogenesis by EDCs. This study clearly shows
that EDC exposure may inﬂuence epigenetic events in vitro,
which warrants further study in vivo. Our ﬁndings indicate the
importance of further investigation of the obesogenic eﬀects of
brominated ﬂame retardants, given the continued exposure of
humans to this class of chemicals.
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